Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Zsófia Müller"'
Autor:
Márton Koch, Éva Pozsgai, Viktor Soós, Anna Nagy, János Girán, Norbert Nyisztor, Tibor Martyin, Zsófia Müller, Melánia Fehér, Edit Hajdú, Csaba Varga
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background West Nile virus (WNV) infections have become increasingly prevalent in certain European countries, including Hungary. Although most human infections do not cause severe symptoms, in approximately 1% of cases WNV infections can lea
Externí odkaz:
https://doaj.org/article/995c10994d4a49d4a588376ac63cfdee
Autor:
Klára Werling, Béla Hunyady, Mihály Makara, Krisztina Nemesi, Gábor Horváth, Ferenc Schneider, Judit Enyedi, Zsófia Müller, Miklós Lesch, Zoltán Péterfi, Tamás Tóth, Judit Gács, Zsuzsanna Fehér, Eszter Ujhelyi, Emese Molnár, Anna Nemes Nagy
Publikováno v:
Viruses, Vol 14, Iss 2, p 308 (2022)
A hepatitis C virus (HCV) screening and treatment program was conducted in Hungarian prisons on a voluntary basis. After HCV-RNA testing and genotyping for anti-HCV positives, treatments with direct-acting antiviral agents were commenced by hepatolog
Externí odkaz:
https://doaj.org/article/458fe4f14d1943199fe10b3f4033986b
Autor:
Klára Werling, Mihály Makara, Krisztina Nemesi, Gábor Horváth, Ferenc Schneider, Ildikó Bali, Judit Enyedi, Viktor Jancsik, András Káfony, Miklós Lesch, Béla Lombay, Zsófia Müller, Zsófia Ozsvár, Árpád Patai, Zoltán Péterfi, Margit Pusztay, Olga Szabó, János Szlávik, Tamás Tóth, Márta Varga, Judit Gács, Eszter Újhelyi, Anna Nemes Nagy
Publikováno v:
Orvosi hetilap. 163(22)
Bevezetés és célkitűzés: Az Európai Unióban a hepatitis C-vírussal (HCV) fertőzött betegek kétharmada nem tud a fertőzöttségéről. A WHO célja 2030-ra az új krónikus hepatitises esetek számának 90%-os csökkentése. A börtönökb
Autor:
Edit Hajdú, Viktor Soós, Márton Koch, Eva Pozsgai, Melánia Fehér, Zsófia Müller, Norbert Nyisztor, János Girán, Tibor Martyin, Csaba Varga, A. Nagy
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-13 (2021)
Background West Nile virus (WNV) infections have become increasingly prevalent in certain European countries, including Hungary. Although most human infections do not cause severe symptoms, in approximately 1% of cases WNV infections can lead to seve
Autor:
Levente Kővágó, Enikő Bán, Orsolya Nagy, Zsuzsanna Várnai, Eszter Molnár, Mária Takács, Zoltán Németh, Emese Henriett Harsányi, Zsófia Müller, A. F. Nagy, Borbála Kecskés, Lajos Jobbágy, Márton Orbán
Publikováno v:
Orvosi Hetilap. 158:791-796
Abstract: Introduction: West Nile virus, a mosquito-borne viral zoonosis is responsible for human infections in Hungary. Laboratory diagnosis is based on serological tests, however the application of molecular methods has been appreciated. Aim: The a
Autor:
Anna, Nagy, Orsolya, Nagy, Enikő, Bán, Eszter, Molnár, Zsófia, Müller, Márton, Orbán, Borbála, Kecskés, Emese Henriett, Harsányi, Levente, Kővágó, Lajos, Jobbágy, Zoltán, Németh, Zsuzsanna, Várnai, Mária, Takács
Publikováno v:
Orvosi hetilap. 158(20)
West Nile virus, a mosquito-borne viral zoonosis is responsible for human infections in Hungary. Laboratory diagnosis is based on serological tests, however the application of molecular methods has been appreciated.The aim of the study was to investi
Autor:
Béla, Hunyady, Margit, Abonyi, Klára, Csefkó, Judit, Gervain, Attila, Haragh, Gábor, Horváth, Viktor, Jancsik, Erzsébet, Makkai, Zsófia, Müller, Pál, Ribiczey, Béla, Sipos, Olga, Szabó, Ferenc, Szalay, László, Szentgyörgyi, István, Tornai, Eszter, Újhelyi, Márta, Varga, György, Weisz, Mihály, Makara
Publikováno v:
Orvosi hetilap. 157(34)
During 2011 and 2013, 155 Hungarian hepatitis C genotype 1 infected patients, mostly with advanced liver fibrosis, who did not respond to prior peginterferon + ribavirin dual therapy, started boceprevir based triple therapy in an early access program
Autor:
István Tornai, Judit Gervain, Klára Csefkó, György Weisz, Mihály Makara, Eszter Ujhelyi, Gábor Horváth, Erzsébet Makkai, Béla Hunyady, Olga Szabó, Ferenc Szalay, László Szentgyörgyi, Béla Sipos, Attila Haragh, M. Abonyi, Viktor Jancsik, Márta Varga, Pál Ribiczey, Zsófia Müller
Introduction: During 2011 and 2013, 155 Hungarian hepatitis C genotype 1 infected patients, mostly with advanced liver fibrosis, who did not respond to prior peginterferon + ribavirin dual therapy, started boceprevir based triple therapy in an early
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5def4f392f36f38be2326bfc0bc98f92
Autor:
Tamás Micsik, Imre Fehérvári, András Gelley, Balázs Nemes, Gergely Zádori, Attila Doros, János Fazakas, Zsófia Müller, Fanni Gelley
Publikováno v:
Interventional Medicine and Applied Science. 3:9-13
Adult-onset Still's disease is a rare systemic non-infectious inflammatory disease of unknown aetiology. It is characterized by high spiking fever, sore throat, arthralgia, transient maculopapular rash, hepatosplenomegaly, liver cytolysis, weight los
Autor:
Elisabeth Nagy, Éva Szekeres, János Lonovics, I. Nagy, Zsófia Müller, Judith Deák, Zsófia Ozsvár, Margit Horányi, György Gál
Publikováno v:
Journal of Clinical Virology. 20:81-83
Background: More than 100 million people are infected with hepatitis C virus (HCV) worldwide. The prevalence of HCV infection varies from country to country and the natural history of hepatitis C infection is not well understood. Objectives: The prev